Research and Markets has announced the addition of the "US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro" report to their offering.
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost.
The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period. Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM).
Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.
Key Topics Covered:
Table Of Contents I
List Of Figures Iii
List Of Charts Iv
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Procedure Codes Investigated
Key Report Updates
Johnson & Johnson
For more information about this report visit http://www.researchandmarkets.com/research/4sh7rr/us_procedure
View source version on businesswire.com: http://www.businesswire.com/news/home/20161117005628/en/Business Wire
Last updated on: 17/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.